Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Share-based Compensation: 2020-2025

Historic Share-based Compensation for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$3.0 million.

  • Molecular Partners Ag's Share-based Compensation fell 29.45% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 78.14%. This contributed to the annual value of $4.7 million for FY2024, which is 19.52% down from last year.
  • Molecular Partners Ag's Share-based Compensation amounted to -$3.0 million in Q3 2025, which was down 203.39% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Share-based Compensation ranged from a high of $5.3 million in Q4 2022 and a low of -$3.5 million during Q3 2023.
  • For the 3-year period, Molecular Partners Ag's Share-based Compensation averaged around $645,900, with its median value being $1,889 (2023).
  • In the last 5 years, Molecular Partners Ag's Share-based Compensation crashed by 49.46% in 2023 and then spiked by 75.55% in 2024.
  • Quarterly analysis of 5 years shows Molecular Partners Ag's Share-based Compensation stood at $4.4 million in 2021, then rose by 19.21% to $5.3 million in 2022, then crashed by 49.46% to $2.7 million in 2023, then surged by 75.55% to $4.7 million in 2024, then fell by 29.45% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q3 2025, $2.9 million for Q2 2025, and $1,270 during Q1 2025.